Literature DB >> 12359055

Differential suppression of human cervical cancer cell growth by adenovirus delivery of p53 in vitro: arrest phase of cell cycle is dependent on cell line.

Woong Shick Ahn1, You Jin Han, Su Mi Bae, Tae-Hyung Kim, Min Seok Rho, Joon Mo Lee, Sung Eun Namkoong, Yong Seok Park, Chong Kook Kim, Jeong-Im Sin.   

Abstract

It has been reported that overexpression of wild-type p53 protein induces suppression of tumor cell growth in vivo and in vitro. In this study, we further evaluated the differential effects of p53 delivered in an adenovirus vector on the cell growth, apoptosis and cell cycle progression in cervical cancer cell lines. We constructed a recombinant adenovirus expressing p53 and then delivered this into cervical carcinoma cell lines (CaSki, SiHa, and HeLa, HeLaS3) along with adenovirus expressing beta-galactosidase as a negative control. Adenovirus-delivered p53 overexpression resulted in a more significant suppression of cell growth in HPV 18-infected cells (HeLa and HeLaS3) and a lesser suppression in HPV 16-infected cells (CaSki and SiHa). However, no suppression was observed in cells infected with a negative control virus. p53 overexpression also induced apoptosis and cell cycle arrest, as determined by annexin V and propidium iodide staining. In particular, the cell cycle was arrested in the G(2)/M phase in CaSki cells. In contrast, cell cycles were arrested in the G(1) phase in HeLa cells, suggesting that the arrest phase is dependent upon the cervical cancer cell line. Taken together, these data support the idea that overexpressed p53 protein plays a differential role in suppressing cervical cancer cell growth through apoptosis and cell cycle arrest in either G(1) or G(2)/M phase, depending on the cancer cell line.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359055      PMCID: PMC5927131          DOI: 10.1111/j.1349-7006.2002.tb02478.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  36 in total

1.  Mdm2 binds p73 alpha without targeting degradation.

Authors:  E Bálint; S Bates; K H Vousden
Journal:  Oncogene       Date:  1999-07-08       Impact factor: 9.867

2.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

Authors:  M Scheffner; K Münger; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Oncoproteins encoded by the cancer-associated human papillomaviruses target the products of the retinoblastoma and p53 tumor suppressor genes.

Authors:  P M Howley; M Scheffner; J Huibregtse; K Münger
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1991

4.  Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.

Authors:  K Hamada; R Alemany; W W Zhang; W N Hittelman; R Lotan; J A Roth; M F Mitchell
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

5.  Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.

Authors:  J Shao; T Fujiwara; Y Kadowaki; T Fukazawa; T Waku; T Itoshima; T Yamatsuji; M Nishizaki; J A Roth; N Tanaka
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

6.  p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.

Authors:  D Spitkovsky; F Aengeneyndt; J Braspenning; M von Knebel Doeberitz
Journal:  Oncogene       Date:  1996-09-05       Impact factor: 9.867

7.  A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.

Authors:  T Fujiwara; E A Grimm; T Mukhopadhyay; D W Cai; L B Owen-Schaub; J A Roth
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

8.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus.

Authors:  P F Su; F Y Wu
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more
  3 in total

1.  Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells.

Authors:  Yong-Seok Lee; Su-Mi Bae; Sun-Young Kwak; Dong-Chun Park; Yong-Wook Kim; Soo-Young Hur; Eun-Kyung Park; Byoung-Don Han; Young-Joo Lee; Chong-Kook Kim; Do Kang Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

Review 2.  Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer.

Authors:  Momeneh Ghanaat; Nasser Hashemi Goradel; Arash Arashkia; Nasim Ebrahimi; Sajjad Ghorghanlu; Ziba Veisi Malekshahi; Esmail Fattahi; Babak Negahdari; Hami Kaboosi
Journal:  Acta Pharmacol Sin       Date:  2021-02-25       Impact factor: 6.150

3.  MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.

Authors:  Neeru Singh; Rashmi Bhakuni; Dimple Chhabria; Sivapriya Kirubakaran
Journal:  BMC Res Notes       Date:  2020-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.